James J. McKinney
Known title: Chief Financial OfficerCIK: 0001654782
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Kemper Q2 earnings reviewed alongside peers. Kemper Corporation's second-quarter results are being analyzed in comparison to other multi-line insurance companies. This review helps investors understand how KMPR performed relative to industry standards. The stock currently trades with a dividend yield of 2.91%, while analysts maintain an average price target of $36.33.
Transaction History
| SPNT | ▼ Sell | Tax Withholding | 3,648 | $78K | 5/31/2026 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 2,620 | $61K | 4/30/2026 | View on chart |
| SPNT | ▲ Buy | Grant | 15,180 | $0 | 4/28/2026 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 2,413 | $0 | 5/31/2025 | View on chart |
| SPNT | ▲ Buy | Grant | 19,508 | $0 | 4/25/2025 | View on chart |
| SPNT | ▲ Buy | Grant | 24,704 | $0 | 6/3/2024 | View on chart |
| KMPR | ▲ Buy | Grant | 4,406 | $0 | 1/31/2023 | View on chart |
| KMPR | ▲ Buy | Grant | 6,786 | $0 | 2/2/2022 | View on chart |
| KMPR | ▼ Sell | Tax Withholding | 2,083 | $110K | 2/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SiriusPoint (SPNT) Valuation Questioned After Recent Price Rise
Recent market discussion has focused on whether SiriusPoint remains undervalued following a recent increase in its share price. The company currently trades with a low trailing P/E ratio of 5.7, which is significantly below the average analyst target of $28.75. This valuation gap has prompted investors to reassess the stock's position within its 52-week range of $17.39 to $26.50.
SiriusPoint (SPNT) Valuation Questioned After Recent Price Rise. Recent market discussion has focused on whether SiriusPoint remains undervalued following a recent increase in its share price. The company currently trades with a low trailing P/E ratio of 5.7, which is significantly below the average analyst target of $28.75. This valuation gap has prompted investors to reassess the stock's position within its 52-week range of $17.39 to $26.50.